When the pattern of use becomes compulsive, leads to withdrawal symptoms, and interferes with work, school, or relationships, it is classified as **Qat dependence** (also called khat use disorder). The condition is listed in the World Health Organization’s International Classification of Diseases (ICD‑11) under “disorders due to psycho‑active substance use.”

Who it affects

• Predominantly men aged 15‑45 in Yemen, Somalia, Ethiopia, Kenya, Djibouti, and parts of Saudi Arabia.
• Immigrant communities in the United Kingdom, United States, Canada, and Australia where khat is imported for cultural use.

Prevalence

• In Yemen, up to 68% of adult men chew qat daily (WHO, 2022).
• Surveys in Ethiopia show a 25–30% prevalence among university students (J. Addict. Res. Ther., 2021).
• Among Somali immigrants in the U.K., 10–15% report regular use (British Journal of Psychiatry, 2020).

Symptoms

Symptoms of Qat dependence can be grouped into physical, psychological, and behavioral categories. Not everyone will experience every symptom, but the presence of several, especially with cravings and withdrawal, indicates a disorder.

Physical Symptoms

• Increased heart rate (tachycardia) – often felt as palpitations.
• Elevated blood pressure – may be mild to moderate.
• Insomnia or disrupted sleep patterns – users often stay awake for 4–6 hours after chewing.
• Loss of appetite – can lead to weight loss over time.
• Dry mouth, sweating, and tremors – common during a chewing session.
• Gastro‑intestinal upset – nausea, abdominal cramps, or constipation.
• Dental problems – chronic chewing can cause gum recession, tooth decay, and xerostomia.
• Headache – often during withdrawal.

Psychological Symptoms

• Euphoria and heightened alertness – the “high” that users seek.
• Increased talkativeness and sociability.
• Anxiety or nervousness – especially at higher doses.
• Paranoia or mild psychotic symptoms – rare but reported with heavy, prolonged use.
• Depressive mood or irritability during withdrawal.
• Cravings – intense desire to chew qat to relieve discomfort.

Behavioral Symptoms

• Spending increasing amounts of time obtaining, preparing, or chewing qat.
• Giving up or reducing other activities (work, school, hobbies) to use qat.
• Unsuccessful attempts to cut down or stop.
• Continued use despite awareness of physical or social problems.
• Financial strain from purchasing large quantities.

Causes and Risk Factors

Qat dependence is multifactorial, involving pharmacologic, social, and individual elements.

Pharmacologic Causes

• Cathinone is a monoamine‑releasing agent that raises dopamine, norepinephrine, and serotonin levels, creating rewarding reinforcement similar to other stimulants.
• Repeated stimulation leads to neuroadaptation—tolerance develops, prompting larger or more frequent doses.

Social & Cultural Factors

• Cultural tradition – In many Horn of Africa societies, qat chewing is a customary social activity, normalizing frequent use.
• Peer pressure – Young adults may start to fit in with friends or colleagues.
• Stressful living conditions – Conflict, displacement, or unemployment can drive people to use qat as a coping mechanism.

Individual Risk Factors

• Male gender – epidemiologic data consistently show higher use among men.
• Young age (adolescence–early adulthood) – Early exposure increases lifetime risk of dependence.
• Genetic predisposition – Polymorphisms in dopamine‑related genes (e.g., DRD2) are associated with stimulant dependence.
• Co‑occurring mental health disorders – Anxiety, depression, or post‑traumatic stress disorder (PTSD) often co‑exist and may exacerbate use.
• Concurrent substance use – Tobacco, alcohol, or cannabis use can compound dependence risk.

Diagnosis

Diagnosis is clinical, based on a thorough history, physical exam, and application of standardized criteria.

Screening Tools

• DSM‑5 criteria for stimulant use disorder – Qat is treated as a stimulant; meeting ≥2 of 11 criteria within a 12‑month period indicates a mild‑to‑severe disorder.
• Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) – Includes a specific item for khat.
• World Health Organization (WHO) ASSIST‑Khat Module – Developed for populations where khat is prevalent.

Clinical Evaluation

1. History: frequency, amount, route, age of onset, attempts to quit, withdrawal experiences, and impact on functioning.
2. Physical exam: cardiovascular assessment (BP, HR), oral health inspection, signs of malnutrition, and mental status exam.
3. Laboratory tests (optional):
   • Urine immunoassay for cathinone – limited availability, mainly for research.
   • Complete blood count (CBC) and metabolic panel – to rule out anemia, electrolyte disturbances.
   • Liver function tests – chronic stimulant use may affect hepatic enzymes.
4. Psychiatric assessment – screening for depression, anxiety, PTSD, or psychosis.

Differential Diagnosis

Conditions that may mimic or coexist with Qat dependence include:

• Other stimulant use disorders (e.g., amphetamine, cocaine)
• Primary anxiety or mood disorders
• Sleep disorders (insomnia, sleep apnea)
• Cardiovascular disease unrelated to stimulant use

Treatment Options

There is no medication specifically approved for Qat dependence, but treatment follows principles used for other stimulant use disorders.

1. Behavioral Interventions

• Cognitive‑Behavioral Therapy (CBT) – Helps identify triggers, develop coping skills, and restructure thoughts about chewing.
• Motivational Interviewing (MI) – Enhances readiness to change and resolves ambivalence.
• Contingency Management (CM) – Provides tangible rewards for verified abstinence (e.g., voucher system).
• 12‑step or peer‑support groups – Adapted to cultural contexts (e.g., “Khat Anonymous”).

2. Pharmacologic Options

Evidence is limited, but some agents have shown promise in small trials or extrapolated from amphetamine dependence.

3. Management of Withdrawal

• Supportive care – Hydration, balanced meals, rest.
• Sleep hygiene – Dim lighting, consistent bedtime, limited caffeine.
• Short‑term use of benzodiazepines (e.g., lorazepam) may relieve severe anxiety or agitation, but should be limited to < 2 weeks.

4. Lifestyle & Complementary Strategies

• Regular aerobic exercise – improves dopamine function and reduces cravings.
• Nutrition counseling – counteracts appetite suppression and weight loss.
• Mindfulness‑based relapse prevention – teaches awareness of urges.
• Dental care – routine check‑ups to address gum disease caused by chewing.

Living with Qat (Khat) Dependence

Successful long‑term recovery involves daily self‑management and a supportive environment.

Practical Tips

1. Set a quit date and write down personal reasons for change.
2. Identify triggers (e.g., social gatherings, stress) and plan alternatives such as tea without qat, sports, or family activities.
3. Track cravings using a journal; note time of day, intensity (1‑10), and coping strategy used.
4. Stay hydrated – Aim for 2–3 L of water daily to offset dry‑mouth effects.
5. Maintain a balanced diet – Include protein, complex carbs, and fruits/vegetables to prevent weight loss.
6. Engage in regular physical activity – 30 minutes most days; exercise reduces stress and improves mood.
7. Seek social support – Talk with family, join a peer‑support group, or involve a counselor.
8. Limit caffeine and other stimulants to avoid cumulative cardiovascular strain.
9. Schedule medical follow‑up every 3–6 months to monitor blood pressure, mental health, and oral health.

Self‑Help Resources

• World Health Organization – Khat Fact Sheet
• Mental Health America – “Stimulant Use Disorder” toolkit
• Local community health centers that offer culturally‑sensitive counseling

Prevention

Preventing Qat dependence starts with education, policy, and community engagement.

• Public education campaigns in high‑risk regions highlighting health risks (cardiovascular, dental, mental health).
• School‑based programs that teach adolescents about substance‑use warning signs.
• Regulation – Many countries limit importation or set age restrictions; enforcing these policies reduces availability.
• Alternative social activities – Promote sports, arts, and cultural events that do not involve chewing.
• Stress‑reduction programs – Offer counseling, vocational training, and community support for displaced or unemployed individuals.

Complications

If left untreated, chronic Qat dependence can lead to serious medical, psychiatric, and social problems.

Medical Complications

• Cardiovascular disease – hypertension, arrhythmias, myocardial infarction.
• Gastro‑intestinal issues – gastritis, constipation, severe weight loss.
• Dental disease – periodontitis, tooth loss.
• Neurological – chronic headaches, tremor, rare seizures.
• Reproductive – reduced sperm count and motility in men; menstrual irregularities in women.

Psychiatric Complications

• Worsening anxiety or depression.
• Psychosis or severe paranoid ideation (especially with high‑dose, prolonged use).
• Increased risk of suicide attempts in individuals with co‑existing mood disorders.

Social & Economic Consequences

• Job loss or decreased productivity.
• Family discord, divorce, or child neglect.
• Financial hardship from continuous purchase of large quantities.
• Legal issues in countries where khat is prohibited.

When to Seek Emergency Care

Even if symptoms are mild but persistent (e.g., ongoing hypertension, chronic insomnia, or severe anxiety), schedule a primary‑care or mental‑health appointment promptly.

Sources: WHO (2022) Khat Fact Sheet; CDC (2023) Substance Abuse Data; Mayo Clinic (2024) Stimulant Use Disorder; National Institute on Drug Abuse (NIDA) – “Khat (Catha edulis).” Peer‑reviewed journals include Journal of Addiction Research & Therapy, British Journal of Psychiatry, and Cleveland Clinic Journal of Medicine. All links accessed May 2026.